Procept Inc. announced Friday that its underwriter, D.Blech &Co., had exercised its overallotment option from the company'sinitial public offering, purchasing 315,000 shares of Proceptcommon stock.

With the overallotment, the Cambridge, Mass., companygarnered $18.6 million in net proceeds on a gross financing of$20.5 million. The company sold a total of 2.4 million shares inits placement, which began trading last week.

Procept's stock (NASDAQ:PRCT) closed at $10.38 on Friday,down 13 cents.

(c) 1997 American Health Consultants. All rights reserved.